Metreleptin in Anorexia Nervosa
Recruiting
Phase 2
Interventional Study
Anorexia Nervosa
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 17 – 65
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Gabriella Milos · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The treatment of anorexia nervosa often proves to be difficult. There are no drugs that work specifically for the treatment of anorexia nervosa. Experimental administration of metreleptin (synthetically produced leptin) to patients with anorexia nervosa has produced positive results. This study tests the effect of metreleptin in comparison with placebo, which could potentially make treatment easie…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Main key inclusion criteria:
* Current diagnosis of AN according to fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) confirmed with Structured Clinical Interview for DSM-5 (SCID-5)
* BMI \> 13 kg/m2; BMI ≤ 18 kg/m2; body weight ≥ 35 kg
* Hospitalisation in the Eati…
Contacts